Literature DB >> 22878989

Presentation of opsoclonus myoclonus ataxia syndrome with glutamic acid decarboxylase antibodies.

Hanul Srinivas Bhandari1.   

Abstract

In this rare case, the patient presented with opsoclonus, myoclonus and ataxia. Serological and imaging studies revealed high glutamic acid decarboxylase antibody (GAD-Ab) levels. High-dose corticosteroids were of no benefit and subsequent intravenous immunoglobulin (IVIg) administration proved resolution of the condition. Levetiracetam proved useful in symptomatically controlling the myoclonus. Follow-up GAD-Ab levels were within normal limits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22878989      PMCID: PMC4543362          DOI: 10.1136/bcr-2012-006339

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

Review 1.  An update on opsoclonus.

Authors:  Agnes Wong
Journal:  Curr Opin Neurol       Date:  2007-02       Impact factor: 5.710

Review 2.  Myoclonus.

Authors:  John N Caviness; Daniel D Truong
Journal:  Handb Clin Neurol       Date:  2011

3.  False positive autoantibodies to glutamic acid decarboxylase in opsoclonus-myoclonus-ataxia syndrome after intravenous treatment with immunoglobulin.

Authors:  F de Beer; M W J Schreurs; E M J Foncke
Journal:  Clin Neurol Neurosurg       Date:  2009-05-12       Impact factor: 1.876

4.  Myoclonic encephalopathy of infants.

Authors:  M Kinsbourne
Journal:  J Neurol Neurosurg Psychiatry       Date:  1962-08       Impact factor: 10.154

5.  HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases.

Authors:  Natlada Kanjanasut; Kammant Phanthumchinda; Roongroj Bhidayasiri
Journal:  Clin Neurol Neurosurg       Date:  2010-04-27       Impact factor: 1.876

6.  N-methyl-D-aspartate receptor autoimmune encephalitis presenting with opsoclonus-myoclonus: treatment response to plasmapheresis.

Authors:  Jonathan H Smith; Radhika Dhamija; Brian D Moseley; Paola Sandroni; Claudia F Lucchinetti; Vanda A Lennon; Orhun H Kantarci
Journal:  Arch Neurol       Date:  2011-08

Review 7.  Paraneoplastic neurological syndromes: unusual presentations of cancer. A practical review.

Authors:  Tareq Braik; Arthur T Evans; Margaret Telfer; Susan McDunn
Journal:  Am J Med Sci       Date:  2010-10       Impact factor: 2.378

8.  Opsoclonus-myoclonus syndrome caused by varicella-zoster virus.

Authors:  Dilip Singh; Manish Sinha; Rajesh Kumar; Rakesh Shukla; R C Ahuja
Journal:  Ann Indian Acad Neurol       Date:  2010-07       Impact factor: 1.383

Review 9.  The neurobiology of the opsoclonus-myoclonus syndrome.

Authors:  M R Pranzatelli
Journal:  Clin Neuropharmacol       Date:  1992-06       Impact factor: 1.592

10.  Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases.

Authors:  Mario-Ubaldo Manto; Marie-Aline Laute; Michèle Aguera; Véronique Rogemond; Massimo Pandolfo; Jérome Honnorat
Journal:  Ann Neurol       Date:  2007-06       Impact factor: 10.422

View more
  1 in total

1.  GABA-A receptor impairment in cerebellar ataxia with anti-glutamic acid decarboxylase antibodies.

Authors:  Yasushi Hosoi; Makiko Suzuki-Sakao; Tatsuhiro Terada; Takashi Konishi; Yasuomi Ouchi; Hiroaki Miyajima; Satoshi Kono
Journal:  J Neurol       Date:  2013-10-05       Impact factor: 4.849

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.